Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Arfin India: Emerging smallcap riding value added aluminium products wave

2018-07-13 moneycontrol
In the business-to-business (B2B) segment it is difficult to win the hearts of customers particularly when products are commoditised. Taking up this challenge, Arfin India, which is into aluminium products, has consistently evolved its product categories through innovative techniques and research to stand tall in its category. During March, the company was conferred 'India’s Best Aluminium Products Manufacturing Company of the Year 2017' by IBC Infomedia, a division of International Brand Consulting Corporation, USA.
ARFIN RICOAUTO 539151 500039 520008 500228 BHUSANSTL 532508 539254 BANCOINDIA JSWSTEEL 500470 TTST TATASTEEL TATLY JSL 500055 ADANITRANS

0
Banco Products (I) Limited - Trading Window

2018-06-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Dividend

2018-05-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Trading Window

2018-03-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Dividend

2018-03-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

0
Banco Products (I) Limited - Record Date

2018-03-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500039 BANCOINDIA

14
Market Live: Nifty breaks 10,200, Sensex sinks 500 pts; all sectoral indices in the red

2018-03-16 moneycontrol
2:50 pm Market Update: Benchmark indices fell sharply in last hour of trade amid political upheaval after the Telugu Desam Party (TDP) formally decided to quit the NDA government.
513262 500325 GOACARBON JIPKY 532915 RELIANCE IDBI RELIGARE HNDZY HDFC 533278 RIGD 500010 CLNDY 509488 GRAVITA RLNIY 509567 YESBANK 500039 EDELWEISS 500116 GRAPHITE 533282 JPASSOCIAT 532648 YYBKY 532922 BANCOINDIA 532843 ZENSARTECH 532532 504067 FORTIS HDFC COALINDIA SSWL 500188 HINDZINC

14
Market Live: Sensex slips 300 pts, Nifty below 10,300; PSU Bank index outshines

2018-03-16 moneycontrol
1:54 pm Market Update: The market was trading near day's low as benchmark indices declined nearly 1 percent each by intense selling in heavyweights - Reliance Industries, HDFC twins, ITC.
513262 500325 GOACARBON JIPKY 532915 RELIANCE IDBI RELIGARE HNDZY 533278 RIGD CLNDY 509488 GRAVITA RLNIY 509567 YESBANK 500039 EDELWEISS 500116 GRAPHITE 533282 JPASSOCIAT 532648 YYBKY 532922 BANCOINDIA 532843 ZENSARTECH 532532 504067 FORTIS COALINDIA SSWL 500188 HINDZINC

14
Market Live: Sensex slips 300 pts, Nifty below 10,300; HDFC, RIL, ITC, Tata Motors drag

2018-03-16 moneycontrol
engine-powered ATR aircraft of IndiGo's maiden flight from Toulouse to New Delhi was aborted and had to return to the French facility due to low oil pressure.
JIPKY 532915 IDBI RELIGARE HNDZY 533278 500570 TATAMOTORS CLNDY 509488 GRAVITA YESBANK 500039 EDELWEISS 500116 GRAPHITE 533282 JPASSOCIAT 532648 YYBKY 532922 BANCOINDIA 532843 ZENSARTECH 532532 504067 FORTIS COALINDIA 500188 HINDZINC TTM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

14h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

15h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...